Haroon Ur Rashid1, Mamoon Rashid2, Nasir Khan2, Shayan Shahid Ansari3, Noshi Bibi2. 1. Plastic Surgery Department, Shifa International Hospital, Pitras Bukhari Road H-8, Islamabad, Pakistan. haroonpmc@hotmail.com. 2. Plastic Surgery Department, Shifa International Hospital, Pitras Bukhari Road H-8, Islamabad, Pakistan. 3. Head and Neck, Shifa International Hospital, Islamabad, Pakistan.
Abstract
BACKGROUND: Most of the head and neck cancers are time-critical and need urgent surgical treatment. Our unit is one of the departments in the region, at the forefront in treating head and neck cancers in Pakistan. We have continued treating these patients in the COVID-19 pandemic with certain modified protocols. The objective of this study is to share our experience and approach towards head and neck reconstruction during the COVID-19 pandemic. RESULTS: There were a total of 31 patients, 20 (64.5%) were males and 11 (35.4%) patients were females. The mean age of patients was 52 years. Patients presented with different pathologies, i.e. Squamous cell carcinoma n = 26 (83.8%), mucoepidermoid carcinoma n = 2 (6.4%), adenoid cystic carcinoma n = 2 (6.4%) and mucormycosis n = 1 (3%). The reconstruction was done with loco-regional flaps like temporalis muscle flap n = 12 (38.7%), Pectoralis major myocutaneous flap n = 8 (25.8%), supraclavicular artery flap n = 10 (32.2%) and combination of fore-head, temporalis major and cheek rotation flaps n = 1 (3%). Defects involved different regions like maxilla n = 11 (35.4%), buccal mucosa n = 6 (19.3%), tongue with floor of mouth n = 6 (19.3%), mandible n = 4 (12.9%), parotid gland, mastoid n = 3 (9.6%) and combination of defects n = 1 (3%). Metal reconstruction plate was used in 3 (9.6%) patients with mandibular defects. All flaps survived, with the maximum follow-up of 8 months and minimum follow-up of 6 months. CONCLUSION: Pedicled flaps are proving as the workhorse for head and neck reconstruction in unique global health crisis. Vigilant use of proper PPE and adherence to the ethical principles proves to be the only shield that will benefit patients, HCW and health system.
BACKGROUND: Most of the head and neck cancers are time-critical and need urgent surgical treatment. Our unit is one of the departments in the region, at the forefront in treating head and neck cancers in Pakistan. We have continued treating these patients in the COVID-19 pandemic with certain modified protocols. The objective of this study is to share our experience and approach towards head and neck reconstruction during the COVID-19 pandemic. RESULTS: There were a total of 31 patients, 20 (64.5%) were males and 11 (35.4%) patients were females. The mean age of patients was 52 years. Patients presented with different pathologies, i.e. Squamous cell carcinoma n = 26 (83.8%), mucoepidermoid carcinoma n = 2 (6.4%), adenoid cystic carcinoma n = 2 (6.4%) and mucormycosis n = 1 (3%). The reconstruction was done with loco-regional flaps like temporalis muscle flap n = 12 (38.7%), Pectoralis major myocutaneous flap n = 8 (25.8%), supraclavicular artery flap n = 10 (32.2%) and combination of fore-head, temporalis major and cheek rotation flaps n = 1 (3%). Defects involved different regions like maxilla n = 11 (35.4%), buccal mucosa n = 6 (19.3%), tongue with floor of mouth n = 6 (19.3%), mandible n = 4 (12.9%), parotid gland, mastoid n = 3 (9.6%) and combination of defects n = 1 (3%). Metal reconstruction plate was used in 3 (9.6%) patients with mandibular defects. All flaps survived, with the maximum follow-up of 8 months and minimum follow-up of 6 months. CONCLUSION: Pedicled flaps are proving as the workhorse for head and neck reconstruction in unique global health crisis. Vigilant use of proper PPE and adherence to the ethical principles proves to be the only shield that will benefit patients, HCW and health system.
Entities:
Keywords:
Head and neck reconstruction; Pedicled flaps in free flap era; Reconstruction in COVID 19 pandemic
Authors: Roman Wölfel; Victor M Corman; Wolfgang Guggemos; Michael Seilmaier; Sabine Zange; Marcel A Müller; Daniela Niemeyer; Terry C Jones; Patrick Vollmar; Camilla Rothe; Michael Hoelscher; Tobias Bleicker; Sebastian Brünink; Julia Schneider; Rosina Ehmann; Katrin Zwirglmaier; Christian Drosten; Clemens Wendtner Journal: Nature Date: 2020-12 Impact factor: 49.962
Authors: Sean Wei Xiang Ong; Yian Kim Tan; Po Ying Chia; Tau Hong Lee; Oon Tek Ng; Michelle Su Yen Wong; Kalisvar Marimuthu Journal: JAMA Date: 2020-04-28 Impact factor: 56.272
Authors: Qing Ye; Biyao Zou; Yee Hui Yeo; Jie Li; Daniel Q Huang; Yuankai Wu; Hongli Yang; Chuanli Liu; Leslie Y Kam; Xiang Xuan Eunice Tan; Nicholas Chien; Sam Trinh; Linda Henry; Christopher Donald Stave; Tetsuya Hosaka; Ramsey C Cheung; Mindie H Nguyen Journal: Lancet Gastroenterol Hepatol Date: 2020-05-12
Authors: Roy S Herbst; Giuseppe Giaccone; Filippo de Marinis; Niels Reinmuth; Alain Vergnenegre; Carlos H Barrios; Masahiro Morise; Enriqueta Felip; Zoran Andric; Sarayut Geater; Mustafa Özgüroğlu; Wei Zou; Alan Sandler; Ida Enquist; Kimberly Komatsubara; Yu Deng; Hiroshi Kuriki; Xiaohui Wen; Mark McCleland; Simonetta Mocci; Jacek Jassem; David R Spigel Journal: N Engl J Med Date: 2020-10-01 Impact factor: 91.245
Authors: Hee Jeong Kim; Laura Dominici; Shoshana M Rosenberg; Yue Zheng; Linda M Pak; Philip D Poorvu; Kathryn J Ruddy; Rulla Tamimi; Lidia Schapira; Steven E Come; Jeffrey Peppercorn; Virginia F Borges; Ellen Warner; Hilde Vardeh; Laura C Collins; Rachel Gaither; Tari A King; Ann H Partridge Journal: Ann Surg Date: 2020-12-23 Impact factor: 13.787
Authors: Ana Caruntu; Liliana Moraru; Raluca Monica Comaneanu; Raluca Simona Costache; Titus Alexandru Farcasiu; Cristian Scheau; Daniel Octavian Costache; Constantin Caruntu Journal: Exp Ther Med Date: 2022-04-01 Impact factor: 2.447